ketoconazole has been researched along with Autoimmune Disease in 9 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ten patients with endogenous uveitis were in clinical remission attributable to treatment with cyclosporine and prednisone." | 9.07 | Combined use of cyclosporine and ketoconazole in the treatment of endogenous uveitis. ( Austin, HA; de Smet, MD; Lopez, JS; Nussenblatt, RB; Rubin, BI; Whitcup, SM, 1992) |
| "Ten patients with endogenous uveitis were in clinical remission attributable to treatment with cyclosporine and prednisone." | 5.07 | Combined use of cyclosporine and ketoconazole in the treatment of endogenous uveitis. ( Austin, HA; de Smet, MD; Lopez, JS; Nussenblatt, RB; Rubin, BI; Whitcup, SM, 1992) |
| "Ketoconazole was administered as a single daily oral dose of 200 mg to 12 patients with chronic mucocutaneous candidosis (CMC) of autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED)." | 2.66 | Ketoconazole is effective against the chronic mucocutaneous candidosis of autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED). ( Ahonen, P; Kahanpää, A; Myllärniemi, S; Perheentupa, J, 1986) |
| "Ketoconazole was effective in controlling symptoms of candidiasis in most patients." | 1.28 | Chronic mucocutaneous candidiasis in childhood and complications of non-Candida infection: a report of the Pediatric Immunodeficiency Collaborative Study Group. ( Herrod, HG, 1990) |
| "Systemic autoimmune diseases are generally treated with immunosuppressive agents." | 1.27 | Immunomodulation in autoimmune diseases. ( Fehér, J; Gergely, P; Gonzalez-Cabello, R; Láng, I, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mohamed, MF | 1 |
| Jungerwirth, S | 1 |
| Asatryan, A | 1 |
| Jiang, P | 1 |
| Othman, AA | 1 |
| da Mota, F | 1 |
| Murray, C | 1 |
| Ezzat, S | 1 |
| Appleboom, TM | 1 |
| Flowers, FP | 1 |
| de Smet, MD | 1 |
| Rubin, BI | 1 |
| Whitcup, SM | 1 |
| Lopez, JS | 1 |
| Austin, HA | 1 |
| Nussenblatt, RB | 1 |
| Herrod, HG | 1 |
| Feuillan, P | 1 |
| Poth, M | 1 |
| Reilly, W | 1 |
| Bright, G | 1 |
| Loriaux, DL | 1 |
| Chrousos, GP | 1 |
| Naito, Y | 1 |
| Yoshikawa, T | 1 |
| Oyamada, H | 1 |
| Tainaka, K | 1 |
| Morita, Y | 1 |
| Kogawa, T | 1 |
| Sugino, S | 1 |
| Kondo, M | 1 |
| Gergely, P | 1 |
| Láng, I | 1 |
| Gonzalez-Cabello, R | 1 |
| Fehér, J | 1 |
| Ahonen, P | 1 |
| Myllärniemi, S | 1 |
| Kahanpää, A | 1 |
| Perheentupa, J | 1 |
3 trials available for ketoconazole and Autoimmune Disease
| Article | Year |
|---|---|
Assessment of effect of CYP3A inhibition, CYP induction, OATP1B inhibition, and high-fat meal on pharmacokinetics of the JAK1 inhibitor upadacitinib.
Topics: Adult; Area Under Curve; Autoimmune Diseases; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome | 2017 |
Combined use of cyclosporine and ketoconazole in the treatment of endogenous uveitis.
Topics: Autoimmune Diseases; Cyclosporine; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies | 1992 |
Ketoconazole is effective against the chronic mucocutaneous candidosis of autoimmune polyendocrinopathy-candidosis-ectodermal dystrophy (APECED).
Topics: Adolescent; Adrenal Insufficiency; Adult; Autoimmune Diseases; Candidiasis; Candidiasis, Chronic Muc | 1986 |
6 other studies available for ketoconazole and Autoimmune Disease
| Article | Year |
|---|---|
Overt immune dysfunction after Cushing's syndrome remission: a consecutive case series and review of the literature.
Topics: Adrenalectomy; Adult; Anti-Infective Agents, Local; Antifungal Agents; Asthma; Autoimmune Diseases; | 2011 |
Ketoconazole in the treatment of chronic mucocutaneous candidiasis secondary to autoimmune polyendocrinopathy-candidiasis syndrome.
Topics: Adolescent; Antifungal Agents; Autoimmune Diseases; Candidiasis; Candidiasis, Chronic Mucocutaneous; | 1982 |
Chronic mucocutaneous candidiasis in childhood and complications of non-Candida infection: a report of the Pediatric Immunodeficiency Collaborative Study Group.
Topics: Adolescent; Amphotericin B; Autoimmune Diseases; Candidiasis; Candidiasis, Chronic Mucocutaneous; Ch | 1990 |
Ketoconazole treatment of type 1 autoimmune polyglandular syndrome: effects on pituitary-adrenal axis.
Topics: Adrenocorticotropic Hormone; Autoimmune Diseases; Candidiasis, Oral; Child; Corticotropin-Releasing | 1986 |
Esophageal candidiasis.
Topics: Amphotericin B; Autoimmune Diseases; Candidiasis; Esophageal Diseases; Esophagoscopy; Female; Humans | 1988 |
Immunomodulation in autoimmune diseases.
Topics: Adjuvants, Immunologic; Autoimmune Diseases; Drug Evaluation; Glutamine; Guanylthiourea; Humans; Imm | 1986 |